HB Fuller Co (NYSE:FUL) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Thursday.

According to Zacks, “H.B. Fuller Company is a worldwide manufacturer and marketer of adhesives, sealants, coatings, paints and other specialty chemical products. The company’s largest worldwide business category is adhesives, sealants and coatings. These products are sold to customers in a wide range of industries, including packaging, woodworking, automotive, aerospace, graphic arts (books/magazines), appliances, filtration, windows, sporting goods, nonwovens, shoes and ceramic tile. “

FUL has been the topic of several other reports. KeyCorp reiterated a “hold” rating on shares of HB Fuller in a research report on Thursday, August 24th. Deutsche Bank AG lifted their price objective on shares of HB Fuller from $56.00 to $58.00 and gave the stock a “hold” rating in a research report on Wednesday, September 6th. BidaskClub upgraded shares of HB Fuller from a “hold” rating to a “buy” rating in a research report on Saturday, June 10th. Finally, Robert W. Baird started coverage on shares of HB Fuller in a research report on Thursday, September 14th. They set a “neutral” rating and a $60.00 price objective on the stock. Two analysts have rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $56.33.

HB Fuller (NYSE:FUL) last posted its quarterly earnings results on Wednesday, June 28th. The specialty chemicals company reported $0.62 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.67 by ($0.05). The company had revenue of $561.65 million during the quarter. HB Fuller had a net margin of 4.25% and a return on equity of 10.69%. During the same quarter in the prior year, the company earned $0.67 earnings per share.

ILLEGAL ACTIVITY WARNING: “Zacks Investment Research Downgrades HB Fuller Co (FUL) to Sell” was originally published by American Banking News and is owned by of American Banking News. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://www.americanbankingnews.com/2017/09/21/zacks-investment-research-downgrades-hb-fuller-co-ful-to-sell.html.

In other news, VP Dietrich J. Crail acquired 970 shares of the stock in a transaction on Wednesday, July 12th. The shares were purchased at an average cost of $51.41 per share, for a total transaction of $49,867.70. Following the transaction, the vice president now owns 970 shares in the company, valued at approximately $49,867.70. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 3.10% of the company’s stock.

Several institutional investors have recently bought and sold shares of the company. BlackRock Inc. grew its holdings in shares of HB Fuller by 0.6% during the 2nd quarter. BlackRock Inc. now owns 6,252,664 shares of the specialty chemicals company’s stock valued at $319,575,000 after acquiring an additional 34,858 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of HB Fuller by 1.0% during the 2nd quarter. Vanguard Group Inc. now owns 5,108,535 shares of the specialty chemicals company’s stock valued at $261,098,000 after acquiring an additional 53,030 shares in the last quarter. Janus Henderson Group PLC purchased a new position in shares of HB Fuller during the 2nd quarter valued at $105,912,000. Dimensional Fund Advisors LP grew its holdings in shares of HB Fuller by 0.8% during the 2nd quarter. Dimensional Fund Advisors LP now owns 2,019,675 shares of the specialty chemicals company’s stock valued at $103,226,000 after acquiring an additional 15,212 shares in the last quarter. Finally, Champlain Investment Partners LLC grew its holdings in shares of HB Fuller by 53.9% during the 1st quarter. Champlain Investment Partners LLC now owns 1,664,330 shares of the specialty chemicals company’s stock valued at $85,813,000 after acquiring an additional 582,945 shares in the last quarter. Institutional investors and hedge funds own 92.37% of the company’s stock.

About HB Fuller

H.B. Fuller Company is a formulator, manufacturer and marketer of adhesives, sealants and other specialty chemical products. The Company’s segments include Americas Adhesives, Europe, India, Middle East and Africa (EIMEA), Asia Pacific, Construction Products and Engineering Adhesives. The Americas Adhesives, EIMEA and Asia Pacific operating segments produce and supply industrial adhesives products for applications in various markets, including durable assembly, nonwoven and hygiene, and textile.

Get a free copy of the Zacks research report on HB Fuller (FUL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for HB Fuller (NYSE:FUL)

Receive News & Ratings for HB Fuller Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller Co and related companies with MarketBeat.com's FREE daily email newsletter.